PMID: 37859449
Get my new book, OZEMPIC: Risks, Benefits, and Natural Alternatives to GLP-1 Weight-Loss Drugs , available as an ebook, audiobook, and softcover (currently on sale for 20% off) If you haven't yet, you can subscribe to our free newsletter
Regulatory and compounding status All three compounds IGF-1 LR3, DES(1-3) IGF-1, and PEG-MGF share the same regulatory status in the United States: none have FDA-approved pharmaceutical formulations
Pipette Tip Benefits For most mass spectrometric-based immunoassays, beads are used for the up-front purification
Evidence on Thyroid and Pancreatic Cancer Risks Review findings suggest that while early studies sparked fears of GLP-1 RAs increasing cancer risks or exacerbating malignancy outcomes, these fears have now been largely tempered by a growing body of reassuring and even positive data